IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS

IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS was reported 92 times

These side effects are most commonly reported by patients taking IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS:

# Side effect Count
0 OFF LABEL USE 18
1 DEATH 14
2 PRODUCT USE IN UNAPPROVED INDICATION 9
3 PATHOGEN RESISTANCE 8
4 DRUG INEFFECTIVE 6
5 CARDIO-RESPIRATORY ARREST 5
6 GENERALISED TONIC-CLONIC SEIZURE 5
7 OVERDOSE 5
8 EPILEPSY 4
9 RENAL IMPAIRMENT 4
10 THERAPY NON-RESPONDER 4
11 CONDITION AGGRAVATED 3
12 EXTRADURAL ABSCESS 3
13 INCORRECT DOSE ADMINISTERED 3
14 INCORRECT PRODUCT ADMINISTRATION DURATION 3
15 KLEBSIELLA BACTERAEMIA 3
16 RESPIRATORY FAILURE 3
17 SEIZURE 3
18 STENOTROPHOMONAS INFECTION 3
19 SUBDURAL ABSCESS 3
20 THROMBOCYTOPENIA 3
21 CARDIAC FAILURE 2
22 COUGH 2
23 DRUG RESISTANCE 2
24 ENCEPHALOPATHY 2
25 EPIDURAL CATHETER PLACEMENT 2
26 FATIGUE 2
27 GLOMERULAR FILTRATION RATE DECREASED 2
28 ILL-DEFINED DISORDER 2
29 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
30 NAUSEA 2
31 NO ADVERSE EVENT 2
32 PANCREATITIS ACUTE 2
33 PARADOXICAL DRUG REACTION 2
34 PRODUCT AVAILABILITY ISSUE 2
35 PRODUCT DOSE OMISSION ISSUE 2
36 PURULENCE 2
37 SEPSIS 2
38 SEPTIC SHOCK 2
39 THERAPY INTERRUPTED 2
40 TREATMENT FAILURE 2
41 TREMOR 2
42 ABSCESS 1
43 ABSCESS DRAINAGE 1
44 ADMINISTRATION SITE EXTRAVASATION 1
45 ADVERSE DRUG REACTION 1
46 ADVERSE EVENT 1
47 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1
48 ARTHRALGIA 1
49 ASPIRATION 1
50 BACK PAIN 1
51 BACTERAEMIA 1
52 BILE DUCT CANCER 1
53 BLADDER DILATATION 1
54 BLOOD POTASSIUM DECREASED 1
55 BRONCHIECTASIS 1
56 C-REACTIVE PROTEIN INCREASED 1
57 CARDIAC DISORDER 1
58 CATHETER SITE INFECTION 1
59 CELLULITIS 1
60 CENTRAL VENOUS CATHETERISATION 1
61 CHOLECYSTITIS 1
62 CHOLESTASIS 1
63 COAGULOPATHY 1
64 COMA 1
65 CONCOMITANT DISEASE AGGRAVATED 1
66 CREATININE RENAL CLEARANCE ABNORMAL 1
67 CULTURE URINE POSITIVE 1
68 DECREASED APPETITE 1
69 DELIRIUM 1
70 DEPRESSED LEVEL OF CONSCIOUSNESS 1
71 DIPLOPIA 1
72 DIZZINESS 1
73 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
74 DRUG ERUPTION 1
75 DYSPNOEA 1
76 EAR DISCOMFORT 1
77 ENTEROCOCCUS TEST POSITIVE 1
78 EXTUBATION 1
79 GASTROINTESTINAL DISORDER 1
80 GRAFT COMPLICATION 1
81 HAEMOFILTRATION 1
82 HAEMOPTYSIS 1
83 HEADACHE 1
84 HEPATIC FUNCTION ABNORMAL 1
85 HYPERSENSITIVITY 1
86 HYPERTENSION 1
87 HYPOACUSIS 1
88 HYPOREFLEXIA 1
89 ILLNESS 1
90 INFECTION 1
91 INFECTIVE ANEURYSM 1
92 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 1
93 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1
94 INFLAMMATORY MARKER INCREASED 1
95 INTENTIONAL UNDERDOSE 1
96 INTESTINAL ANASTOMOSIS 1
97 LARYNGOSPASM 1
98 LUNG INFILTRATION 1
99 MICROBIOLOGY TEST ABNORMAL 1
100 MORNING SICKNESS 1
101 MULTIMORBIDITY 1
102 MUSCLE SPASMS 1
103 MUSCULAR WEAKNESS 1
104 MYASTHENIA GRAVIS 1
105 MYOCLONIC EPILEPSY 1
106 NASOPHARYNGITIS 1
107 NERVOUSNESS 1
108 NODULE 1
109 NOSOCOMIAL INFECTION 1
110 OTOTOXICITY 1
111 OXYGEN SATURATION DECREASED 1
112 OXYGEN THERAPY 1
113 PAROTITIS 1
114 PERIPHERAL SWELLING 1
115 PNEUMONIA 1
116 PNEUMONIA PSEUDOMONAL 1
117 POSTICTAL STATE 1
118 PROCALCITONIN INCREASED 1
119 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1
120 PRODUCT ADMINISTRATION INTERRUPTED 1
121 PRODUCT LABEL CONFUSION 1
122 PRODUCT USE ISSUE 1
123 PRODUCTIVE COUGH 1
124 PULMONARY EMBOLISM 1
125 PURULENT DISCHARGE 1
126 PYREXIA 1
127 RUPTURED CEREBRAL ANEURYSM 1
128 SEIZURE LIKE PHENOMENA 1
129 SINUS TACHYCARDIA 1
130 SKIN GRAFT 1
131 STRESS 1
132 SURGERY 1
133 SYSTEMIC CANDIDA 1
134 TINNITUS 1
135 TRACHEOSTOMY 1
136 TRANSPLANT FAILURE 1
137 TUBULOINTERSTITIAL NEPHRITIS 1
138 URINARY TRACT INFECTION 1
139 VASOPLEGIA SYNDROME 1
140 VISION BLURRED 1
141 VOMITING 1